BRIEF published on 04/04/2025 at 18:05, 8 months ago Sartorius to Acquire MatTek from BICO AB Drug Development Regulatory Approval Mergers & Acquisitions 3D Microtissue Models Cell Culture
PRESS RELEASE published on 04/04/2025 at 18:00, 8 months ago Sartorius to acquire microtissue business MatTek from Swedish BICO AB Sartorius to acquire microtissue business MatTek from Swedish BICO AB, advancing cell culture portfolio with 3D models and primary cells for drug development. Acquisition expands Lab Products & Services division Acquisition Sartorius Microtissue MatTek BICO AB
BRIEF published on 03/31/2025 at 14:17, 8 months 4 days ago ISCC Plus certifications pave the way for renewable plastics at Sartorius Sustainability Sartorius Biopharmaceuticals ISCC Plus Renewable Plastics
PRESS RELEASE published on 03/31/2025 at 14:12, 8 months 4 days ago First ISCC Plus certifications pave the way for renewable plastics at Sartorius Sartorius receives ISCC Plus certificates for its production sites in France and UK, advancing renewable plastics production and sustainability efforts Sustainability Sartorius Certification ISCC Plus Renewable Plastics
BRIEF published on 03/27/2025 at 15:18, 8 months 8 days ago Sartorius AG Approves Dividend at Annual General Meeting Financial Results Annual General Meeting Life Sciences Dividend Sartorius AG
PRESS RELEASE published on 03/27/2025 at 15:13, 8 months 8 days ago Sartorius AG - Resolutions of the Annual General Meeting Sartorius AG shareholders approve dividend proposal at Annual General Meeting. Total amount disbursed 50.7 million euros, dividend payable on April 1, 2025 Annual General Meeting Shareholders Dividend Proposal Sartorius AG Dividend Payout
BRIEF published on 02/17/2025 at 10:05, 9 months 15 days ago Sartorius Releases 2024 Annual Report Financial Performance Life Sciences Sartorius Annual Report 2024 Bioprocess Solutions
PRESS RELEASE published on 02/17/2025 at 10:00, 9 months 15 days ago Sartorius releases Annual Report for 2024 Sartorius releases Annual Report for 2024. The life science company showcases financial performance and future outlook. For more details, visit the provided link Financial Performance Annual Report Sartorius 2024 Life Science
BRIEF published on 02/07/2025 at 15:53, 9 months 25 days ago Sartorius AG Proposes Dividend for 2024 Annual General Meeting Financial News Dividend Proposal Sartorius AG 2024 Fiscal Year
PRESS RELEASE published on 02/07/2025 at 15:48, 9 months 25 days ago The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share The Supervisory Board of Sartorius AG proposes a dividend of 0.74 euros per preference share for fiscal 2024. Dividend payment on April 1, 2025 Annual General Meeting Dividend Supervisory Board Sartorius AG Preference Share
Published on 12/05/2025 at 02:35, 4 hours 33 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 8 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 3 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 8 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 37 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 17 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 42 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 52 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 57 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 8 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 23 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 23 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
